Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high prevalence of mutators in this setting strongly contrasts with what has been documented for onset of chronic infections (10%) [83], environment (6%) [84], or acute infections (<1%) [85].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
COMPETITION BETWEEN HIGH AND LOW MUTATING STRAINS OF ESCHERICHIA COLI
Chao, L., & Cox, E. C. (1983) · Evolution · doi:10.1111/j.1558-5646.1983.tb05521.x · Cited by 255
Research works printed but not linked: 39
- Al-Aloul, 2005, Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES, J Cyst Fibros, 4, 197, 10.1016/j.jcf.2005.05.017 · doi:10.1016/j.jcf.2005.05.017
- Armstrong, 2002, Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic, Am J Respir Crit Care Med, 166, 983, 10.1164/rccm.200204-269OC · DOI · Paper page
- Armstrong, 2003, Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics, J Clin Microbiol, 41, 2266, 10.1128/JCM.41.5.2266-2267.2003 · doi:10.1128/jcm.41.5.2266-2267.2003
- Baquero, 2004, Polymorphic mutation frequencies in Escherichia coli : emergence of weak mutators in clinical isolates, J Bacteriol, 186, 5538, 10.1128/JB.186.16.5538-5542.2004 · DOI
- Blazquez, 2003, Hypermutation as a factor contributing to the acquisition of antimicrobial resistance, Clin Infect Dis, 37, 1201, 10.1086/378810 · DOI · Paper page
- Burns, 2001, Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis, J Infect Dis, 183, 444, 10.1086/318075 · DOI · Paper page
- Butler, 1995, Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?, J Clin Microbiol, 33, 1001, 10.1128/JCM.33.4.1001-1004.1995 · doi:10.1128/jcm.33.4.1001-1004.1995
- Chambers, 2005, Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis, Eur Respir J, 26, 651, 10.1183/09031936.05.00126704 · doi:10.1183/09031936.05.00126704
- Cheng, 1996, Spread of a β -lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic, Lancet, 348, 639, 10.1016/S0140-6736(96)05169-0 · DOI
- Ciofu, 2005, Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation, Antimicrob Agents Chemother, 49, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
- Curran, 2005, Commercial mushrooms and bean sprouts are a source of Pseudomonas aeruginosa., J Clin Microbiol, 43, 5830, 10.1128/JCM.43.11.5830-5831.2005 · doi:10.1128/jcm.43.11.5830-5831.2005
- Edenborough, 2004, Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation, J Cyst Fibros, 3, 37, 10.1016/j.jcf.2003.12.007 · doi:10.1016/j.jcf.2003.12.007
- Gibson, 2003, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care Med, 168, 918, 10.1164/rccm.200304-505SO · DOI · Paper page
- Goldberg, 2000, Pseudomonas : global bacteria, Trends Microbiol, 8, 55, 10.1016/S0966-842X(99)01671-6 · DOI
- Gutiérrez, 2004, Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients, Antimicrob Agents Chemother, 48, 3573, 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
- Hall, 2006, Hypermutable bacteria isolated from humans – a critical analysis, Microbiology, 152, 2505, 10.1099/mic.0.29079-0 · DOI · Paper page
- Herman, 1981, Escherichia coli K12 clones that overproduce dam methylase are hypermutable, J Bacteriol, 145, 644, 10.1128/JB.145.1.644-646.1981 · DOI
- Hogardt, 2006, Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates, Int J Med Microbiol, 296, 313, 10.1016/j.ijmm.2005.12.018 · doi:10.1016/j.ijmm.2005.12.018
- Jones, 2001, Spread of a multi-resistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic, Lancet, 358, 557, 10.1016/S0140-6736(01)05714-2 · DOI · Paper page
- Jones, 2003, Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross-infection outbreak, Thorax, 58, 525, 10.1136/thorax.58.6.525 · DOI
- Kelly, 1983, Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 17, 159, 10.1128/JCM.17.1.159-.1983 · doi:10.1128/jcm.17.1.159-.1983
- Maciá, 2004, Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa with the Etest and disk diffusion, Antimicrob Agents Chemother, 48, 2665, 10.1128/AAC.48.7.2665-2672.2004 · DOI
- Maciá, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob Agents Chemother, 49, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
- Maciá, 2006, Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa, Antimicrob Agents Chemother, 50, 975, 10.1128/AAC.50.3.975-983.2006 · DOI
- McCallum, 2001, Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa, Lancet, 358, 558, 10.1016/S0140-6736(01)05715-4 · doi:10.1016/s0140-6736(01)05715-4
- Obmolova, 2000, Crystal structure of mismatch repair protein MutS and its complex with a substrate DNA, Nature, 407, 703, 10.1038/35037509 · DOI · Paper page
- Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
- Oliver, 2002, The mismatch repair system ( mutS, mutL and uvrD genes) in Pseudomonas aeruginosa : molecular characterisation of naturally occurring mutants, Mol Microbiol, 43, 1641, 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
- Oliver, 2004, Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections, Antimicrob Agents Chemother, 48, 4226, 10.1128/AAC.48.11.4226-4233.2004 · DOI
- Panagea, 2005, Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and a study of its survival on dry surfaces, J Hosp Infect, 59, 102, 10.1016/j.jhin.2004.09.018 · DOI
- Prunier, 2003, High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains, J Infect Dis, 187, 1709, 10.1086/374937 · DOI · Paper page
- Román, 2004, Dynamics of long-term colonisation of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains, J Clin Microbiol, 42, 1450, 10.1128/JCM.42.4.1450-1459.2004 · DOI
- Römling, 1994, A major cystic fibrosis clone common to patients and aquatic habitats, Appl Environ Microbiol, 60, 1734, 10.1128/AEM.60.6.1734-1738.1994 · DOI · Paper page
- Rosche, 1999, The role of transient hypermutators in adaptive mutation in Escherichia coli, Proc Natl Acad Sci U S A, 96, 6862, 10.1073/pnas.96.12.6862 · DOI · Paper page
- Salunkhe, 2005, A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance, J Bacteriol, 187, 4908, 10.1128/JB.187.14.4908-4920.2005 · DOI · Paper page
- Scott, 2004, Identification and characterisation of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales, J Med Microbiol, 53, 609, 10.1099/jmm.0.45620-0 · DOI
- Spilker, 2004, PCR-based assay for the differentiation of Pseudomonas aeruginosa from other species of Pseudomonas recovered from cystic fibrosis patients, J Clin Microbiol, 42, 2074, 10.1128/JCM.42.5.2074-2079.2004 · DOI · Paper page
- Taylor, 1992, Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis, Thorax, 47, 426, 10.1136/thx.47.6.426 · DOI
- Watson, 2004, Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum, Microbiology, 150, 2947, 10.1099/mic.0.27230-0 · DOI
Cited by
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Rice, S. A., Tan, C. H., Mikkelsen, P. J., Kung, V., Woo, J., Tay, M., Hauser, A., McDougald, D., Webb, J. S., & Kjelleberg, S. (2009) · The ISME Journal · doi:10.1038/ismej.2008.109 · Cited by 380
Mena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., & Oliver, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01147-08 · Cited by 251
“aeruginosa is highly illustrative; the prevalence of mutators has been reported to be 1% in acute infections (6), 5 to 10% in environmental and early CF isolates (11), and 30 to 60% in longterm CRI (1, 16, 24).”
BackgroundMechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Metadata
- Authors
- Kenna, D. T., Doherty, C. J., Foweraker, J., Macaskill, L., Barcus, V. A., & Govan, J. R. W.
- Affiliations
- Cystic Fibrosis Group, Centre for Infectious Diseases, University of Edinburgh Medical School, The Chancellor’s Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
- Department of Microbiology, Papworth Hospital NHS Trust, Papworth Everard, Cambridge CB3 8RE, UK
- The Whitchurch Laboratory, Department of Microbiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria 3800, Australia
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2007-06-01
- Volume
- 153
- Issue
- 6
- Pages
- 1852-1859
- ISSN
- 1350-0872
- 1465-2080
- Cited by
- 57
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.